Joost CM Meijers

Biochemist
Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands

Presentation(s):

• OC 32.3 - Anti-β2-glycoprotein I antibodies cause activated protein C resistance by interfering with Factor V cleavage at Arginine 506

  Monday, July 11, 2022
  11:15 AM – 11:30 AM

• PB0578 - Generation and characterization of novel nanobodies inhibiting factor XI function

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0631 - VhH anti-thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0862 - Platelet activation via glycoprotein VI initiates thrombin generation: a potential role for platelet-derived factor IX?

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0984 - Direct comparison of Andexanet alfa and prothrombin complex concentrates in the reversal of direct factor Xa inhibitors – An in vitro study

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1272 - CRISPR-Based Knockout Red Blood Cells as Tools to Study Red Blood Cell Surface Protein Involvement in Thrombosis

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• OC 74.5 - Factor XI and Plasma Kallikrein apple domain structures reveal alternate kininogen bound complexes

  Wednesday, July 13, 2022
  11:15 AM – 11:30 AM